Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$0.17 - $765.0 $3,400 - $15.3 Million
20,000 Added 111.31%
37,968 $6,000
Q2 2022

Aug 12, 2022

BUY
$0.27 - $0.71 $4,851 - $12,757
17,968 New
17,968 $5,000
Q1 2022

May 16, 2022

SELL
$0.38 - $1.07 $4,716 - $13,281
-12,413 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$1.03 - $2.48 $12,785 - $30,784
12,413 New
12,413 $13,000

Others Institutions Holding JAGX

About Jaguar Health, Inc.


  • Ticker JAGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 119,861,000
  • Market Cap $125M
  • Description
  • Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfecti...
More about JAGX
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.